NICOTINE AND COTININE URINE Test
Test Name: NICOTINE AND COTININE URINE Test
Components: Nicotine and cotinine
Price: 1870.0 AED
Sample Condition: 10 mL (5 mL min.) random urine in a sterile screw capped container. Ship refrigerated or frozen. Duly filled Test Send Out Consent Form is mandatory.
Report Delivery: Sample by 7th of the month; Report after 2-3 weeks
Method: LC-MS/MS
Test type: Drugs of Abuse
Doctor: Physician, Psychiatrist
Test Department: OS
Pre Test Information: Duly filled Test Send Out Consent Form is mandatory.
Test Details:
Nicotine and cotinine urine tests are used to detect the presence of nicotine and its metabolite cotinine in a person’s urine. These tests are commonly used to determine tobacco or nicotine product use, including cigarettes, cigars, smokeless tobacco, and nicotine replacement therapies.
The presence of nicotine and cotinine in urine can provide information about recent tobacco or nicotine product use, as these substances are rapidly metabolized and excreted in the urine. The tests can also help monitor tobacco cessation efforts and ensure compliance with smoke-free policies.
To perform the test, a urine sample is collected from the individual and sent to a laboratory for analysis. The laboratory will use various methods, such as immunoassays or liquid chromatography, to detect and quantify the levels of nicotine and cotinine in the urine.
It is important to note that nicotine and cotinine urine tests cannot distinguish between different sources of nicotine exposure, such as secondhand smoke or nicotine replacement therapies. Additionally, the tests may not accurately reflect recent nicotine use in individuals with impaired kidney function, as the excretion of nicotine and cotinine may be altered.
Overall, nicotine and cotinine urine tests are valuable tools in assessing tobacco or nicotine product use and monitoring tobacco cessation efforts. However, they should be used in conjunction with other clinical information and counseling to provide a comprehensive assessment of an individual’s tobacco or nicotine use habits.
Test Name | NICOTINE AND COTININE URINE Test |
---|---|
Components | |
Price | 1870.0 AED |
Sample Condition | 10 mL (5 mL min.) random urine in a sterile screw capped container. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory. |
Report Delivery | Sample by 7th of the month; Report after 2??3 weeks |
Method | LC-MS/MS |
Test type | Drugs of Abuse |
Doctor | Physician, Psychiatrist |
Test Department: | OS |
Pre Test Information | Duly filled Test Send Out Consent Formis mandatory. |
Test Details |
Nicotine and cotinine urine tests are used to detect the presence of nicotine and its metabolite cotinine in a person’s urine. These tests are commonly used to determine tobacco or nicotine product use, including cigarettes, cigars, smokeless tobacco, and nicotine replacement therapies. The presence of nicotine and cotinine in urine can provide information about recent tobacco or nicotine product use, as these substances are rapidly metabolized and excreted in the urine. The tests can also help monitor tobacco cessation efforts and ensure compliance with smoke-free policies. To perform the test, a urine sample is collected from the individual and sent to a laboratory for analysis. The laboratory will use various methods, such as immunoassays or liquid chromatography, to detect and quantify the levels of nicotine and cotinine in the urine. It is important to note that nicotine and cotinine urine tests cannot distinguish between different sources of nicotine exposure, such as secondhand smoke or nicotine replacement therapies. Additionally, the tests may not accurately reflect recent nicotine use in individuals with impaired kidney function, as the excretion of nicotine and cotinine may be altered. Overall, nicotine and cotinine urine tests are valuable tools in assessing tobacco or nicotine product use and monitoring tobacco cessation efforts. However, they should be used in conjunction with other clinical information and counseling to provide a comprehensive assessment of an individual’s tobacco or nicotine use habits. |